Korting HC - Search Results

1

Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi.

Borelli C, Schaller M, Niewerth M, Nocker K, Baasner B, Berg D, Tiemann R, Tietjen K, Fugmann B, Lang-Fugmann S, Korting HC. Borelli C, et al. Among authors: korting hc. Chemotherapy. 2008;54(4):245-59. doi: 10.1159/000142334. Epub 2008 Jun 30. Chemotherapy. 2008. PMID: 18587237 Free PMC article.

2

Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors.

Niewerth M, Kunze D, Seibold M, Schaller M, Korting HC, Hube B. Niewerth M, et al. Among authors: korting hc. Antimicrob Agents Chemother. 2003 Jun;47(6):1805-17. doi: 10.1128/AAC.47.6.1805-1817.2003. Antimicrob Agents Chemother. 2003. PMID: 12760852 Free PMC article.

3

Management of onychomycoses.

Niewerth M, Korting HC. Niewerth M, et al. Among authors: korting hc. Drugs. 1999 Aug;58(2):283-96. doi: 10.2165/00003495-199958020-00005. Drugs. 1999. PMID: 10473020 Review.

4

Hydrolytic enzymes as virulence factors of Candida albicans.

Schaller M, Borelli C, Korting HC, Hube B. Schaller M, et al. Among authors: korting hc. Mycoses. 2005 Nov;48(6):365-77. doi: 10.1111/j.1439-0507.2005.01165.x. Mycoses. 2005. PMID: 16262871 Review.

5

Targeting virulence: a new paradigm for antifungals.

Gauwerky K, Borelli C, Korting HC. Gauwerky K, et al. Among authors: korting hc. Drug Discov Today. 2009 Feb;14(3-4):214-22. doi: 10.1016/j.drudis.2008.11.013. Epub 2009 Jan 17. Drug Discov Today. 2009. PMID: 19152839 Review.

6

Direct evidence for uptake of intact liposomes encapsulating silver sulfadiazine by cultured human keratinocytes based on combined transmission electron microscopy and X-ray microanalysis.

Schaller M, Wurm R, Korting HC. Schaller M, et al. Among authors: korting hc. Antimicrob Agents Chemother. 1997 Mar;41(3):717-9. doi: 10.1128/AAC.41.3.717. Antimicrob Agents Chemother. 1997. PMID: 9056023 Free PMC article.

7

Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients.

Korting HC, Schaller M, Eder G, Hamm G, Böhmer U, Hube B. Korting HC, et al. Antimicrob Agents Chemother. 1999 Aug;43(8):2038-42. doi: 10.1128/AAC.43.8.2038. Antimicrob Agents Chemother. 1999. PMID: 10428932 Free PMC article.

8

Current and future approaches to antimycotic treatment in the era of resistant fungi and immunocompromised hosts.

Bastert J, Schaller M, Korting HC, Evans EG. Bastert J, et al. Among authors: korting hc. Int J Antimicrob Agents. 2001 Feb;17(2):81-91. doi: 10.1016/s0924-8579(00)00323-x. Int J Antimicrob Agents. 2001. PMID: 11165110 Review.

9

[New developments in medical mycology].

Korting HC, Schaller M. Korting HC, et al. Hautarzt. 2001 Feb;52(2):91-7. doi: 10.1007/s001050051271. Hautarzt. 2001. PMID: 11244898 Review. German.

10

[Mode of action of ciclopiroxolamine on Candida albicans].

Niewerth M, Schaller M, Korting HC, Hube B. Niewerth M, et al. Among authors: korting hc. Mycoses. 2002;45 Suppl 1:63-8. doi: 10.1111/j.1439-0507.2002.tb04549.x. Mycoses. 2002. PMID: 12073566 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters